Literature DB >> 24278839

Kampo Extract of Shinbuto Improved Refractory Diarrhea in Milroy's Disease.

Yuko Horiba1, Tetsuhiro Yoshino, Kenji Watanabe.   

Abstract

Milroy's disease is a hereditary congenital lymphedema caused by lymphatic obstruction. The legs are most commonly affected, but impaired intestinal lymphatic flow can cause loose bowel movements. Here, we report the use of the Kampo extract of shinbuto for successful treatment of and abdominal pain in a patient with Milroy's disease. Milroy's disease was diagnosed because of left leg lymph-edema with onset at birth. Conservative therapy with a compression bandage was applied. However, when the patient moved to Manila at 35 years of age, she was exposed to drastic temperature changes between the air-conditioned cold environment in her room and the hot and humid environment outside. She developed a constitutional state of coldness as in hiesho (え). Then sudden lower abdominal pain and diarrhea began to occur 3 times per week and lasted at least 1 hour, sometimes accompanied by vomiting. It happened particularly when she was exposed to the cold environment and was not related to meals. Conventional anti-cholinergic or antidiarrhetic drugs had no therapeutic effect. These attacks continued in the same frequency for 3 years, so the patient visited a Kampo (traditional Japanese medicine) clinic, where her diagnosis of Milroy's disease-associated diarrhea and abdominal pain was augmented by the Kampo diagnosis of hiesho, suitai (body fluid retention). She was prescribed 7.5 g of shinbuto extract per day (TJ-30; Tsumura Co, Tokyo, Japan). The shinbuto extract significantly reduced abdominal pain and refractory diarrhea to about 2 days per month, and it tapered off completely in 3 months. Shinbuto is usually used against cold-induced diarrhea. Rewarming and water movement by shinbuto resulted in significant improvement in symptoms induced by hiesho and suitai triggered by the cold environment, though the patient's leg swelling did not change.

Entities:  

Keywords:  Diarrhea; Kampo medicine; Milroy's disease; body fluid retention (suitai); coldness (hie); lymphedema

Year:  2013        PMID: 24278839      PMCID: PMC3833580          DOI: 10.7453/gahmj.2013.2.1.003

Source DB:  PubMed          Journal:  Glob Adv Health Med        ISSN: 2164-9561


INTRODUCTION

Lymphedema is characterized by delayed lymphatic flow and excessive fluid retention. Its overall prevalence is 0.13% to 2%, and more men are affected than women (ratio, 10:1).- Lymphedema can be primary (lymphedema of a single leg or rarely of both legs with onset at birth) or secondary (lymphedema due to excision or destruction of the lymph nodes following surgery for breast and ovarian cancer or lymphangitis following radiation therapy). Diagnosis of secondary lymphedema is excluded on the basis of a combination of history of surgery and radiation therapy, lymphangiography, computed tomography, or magnetic resonance imaging.- Milroy's disease is a form of congenital lymph-edema caused by genetic abnormality of the vascular endothelial growth factor receptor 3 (VEGFR-3). It is considered to be of autosomal dominant inheritance, but some solitary cases have been reported. In Milroy's disease, lymphedema develops within 2 years of birth. Generally, the symptoms include swelling of the extremities, an oppressive feeling, deep tissue ache, general fatigue, and diarrhea. In Milroy's disease, diarrhea is often induced by protein-losing enteropathy due to dilatation of bowel lymphatic vessels and steatorrhea caused by cholestatis. Here we report the use of Kampo extract of shinbuto for a successful treatment of refractory diarrhea and abdominal pain in a patient with Milroy's disease.

CASE PRESENTATION

A 38-year-old woman visited the clinic of the Center for Kampo Medicine at Keio University Hospital, Tokyo, Japan, for refractory diarrhea. She had left leg lymphedema since birth, for which she was diagnosed with Milroy's disease. According to the International Society of Lymphology (ISL) staging system (Table 1), lymphedema was classified as late stage 2 because of chronic edema of the left leg and clearly organized fibrosis. Even though Milroy's disease is known to be a hereditary disorder, this patient did not have a family history of lymphedema. As in a previously reported case, she had been experiencing coldness and occasional abdominal pain without any other symptoms since she was 20 years old. She had undergone plastic surgery to remove fibromatous tissue from her legs twice when she was child. She had been using a compression bandage for the edema in the left leg (Figure 1). When she was 35 years old, she moved to Manila, where she was exposed to significant temperature variations between the cold temperature in an air-conditioned room and the hot temperature outside. Even though the weather outside was hot and humid, she contracted a severe cold and experienced frequent episodes of lower abdominal pain and watery diarrhea (more than six times a day). There was no fever or tenesmus. The abdominal pain occurred about 3 days per week for 3 years and lasted for at least 1 hour and was sometimes accompanied by vomiting. Diarrhea was also induced by drinking room-temperature water. When diarrhea and abdominal pain occurred, her left leg lymphedema worsened as well. The symptoms of diarrhea, abdominal pain, and leg lymphedema were relieved by taking a hot bath. The patient had not been diagnosed with allergies, intestinal parasites, infections, or gastrointestinal disorders in the past. Because loperamide hydrochloride or lactomin had not produced results over the previous 3 years, she visited the Kampo clinic.
Table 1

Lymphedema disease staging according to the International Society of Lymphology (ISL)

ISL stageDescription
0A subclinical state where swelling is not evident despite impaired lymph transport. This stage may exist for months or years before edema becomes evident.
1Early onset of the condition where there is accumulation of tissue fluid that subsides with limb elevation. The edema may be pitting at this stage.
2Limb elevation alone rarely reduces swelling, and pitting is manifested.
Late 2There may or may not be pitting as tissue fibrosis is more evident.
3The tissue is hard (fibrotic) and pitting is absent. Skin changes such as thickening, hyperpigmentation, increased skin folds, fat deposits, and warty over-growths develop.

Figure 1 Patient's legs at 20 years old. The left leg is edematous, and two operations to remove fibromatous tissue had been performed. The patient used bandages for edema all the time. At the first visit, the left leg was bandaged, and the patient said the leg's condition was the same as in this picture.

Lymphedema disease staging according to the International Society of Lymphology (ISL) Figure 1 Patient's legs at 20 years old. The left leg is edematous, and two operations to remove fibromatous tissue had been performed. The patient used bandages for edema all the time. At the first visit, the left leg was bandaged, and the patient said the leg's condition was the same as in this picture.

Clinical Course

The patient did not present with obvious symptomatology other than Milroy's disease, and she did not have any family history of lymphedema. Physical examination revealed that she was 157 cm in height and 52 kg in weight; her body mass index was 21.1, blood pressure was 123/78 mmHg, and pulse was regular at 72 beats per minute. Physique, complexion, and skin were normal. There was significant pitting edema on the left leg, which was approximately twice the diameter of the right leg (Figure 1). There were no obvious abnormal findings on blood and urine analysis, including analysis of total protein, total cholesterol, hemoglobin, and iron. Stool analysis and imaging studies (eg, computed tomography, magnetic resonance imaging, and endos-copy) were not performed because the patient did not report changes in appetite, body weight, or food intolerance while she was living in Manila. At the Kampo clinic, tongue inspection revealed dental indentations (shikon) caused by body fluid retention (suitai) (Figure 2). On abdominal examination (fukushin), abdominal strength (fukuryoku) was slightly deficient; there were no other significant abnormal findings. Based on these findings, we diagnosed the patient with coldness (hiesho) caused by suitai and the body energy deficiency pattern (kyosho).

Figure 2 Dental indentations in the tongue. Dental indentations indicate suitai (body fluid retention).

Figure 2 Dental indentations in the tongue. Dental indentations indicate suitai (body fluid retention). We prescribed 7.5 g of shinbuto per day (regular adult dosage) for cold, lymphedema, and diarrhea. The frequency of diarrhea decreased from six to two times per day after 2 weeks of treatment. In addition, abdominal pain and vomiting improved to 2 days per month and tapered off in 3 months, and the lymph-edema did not worsen. Four years after her first visit, the patient continues to take the same Kampo medicine exclusively and she does not have diarrhea or abdominal pain.

DISCUSSION

Congenital lymphedema is a chronic condition with no cure at present. Proper management of the disease with lymph drainage, pressure therapy, and exercise may alleviate symptoms. Further, surgical repositioning of lymphatic vessel anastomosis or waste fluid road may be performed. However, complete healing is not expected. This article presents a case of refractory diarrhea complicated by Milroy's disease that was treated successfully with shinbuto extract. In Kampo medicine, coldness (hie) is a subjective feeling often occurring at the extremities, abdomen, and low back; if the feeling disturbs one's daily living, it is diagnosed as hiesho (hie means body coldness and sho means constitutional pattern). Hie is caused by hypometabolism, body fluid retention (suitai), or blood circulation disturbance (oketsu). In this case, congenital lymphatic obstruction caused the continuous leg lymphedema, which induced hie (body coldness) and suitai (body fluid retention). Then the exposure to air conditioning in Manila triggered attacks of sudden diarrhea with severe abdominal pain. Rewarming and water movement by shinbuto resulted in significant improvement in symptoms and quality of life. Shinbuto is one of the 148 Kampo extract preparations covered by Japan's National Health Insurance Program. It is indicated for chronic gastroenteritis, indigestion, gastroptosia, abdominal pain, and diarrhea with watery, foamy, viscous, or bloody stool. According to the well-known Kampo physician Keisetsu Otsuka, Shinbuto is used for people with kyosho (energy deficiency pattern) and weak intestines, including loose bowel or chronic diarrhea. However, we can also use it for patients without diarrhea. I have used it for edemas of the paralysis, chronic hypo-tension, cerebral hemorrhage, gastric atony symptoms, gastroptosia and chronic enteritis.– Shinbuto contains Aconiti tuber (processed aconite root), Zingiberis rhizoma (ginger), Poria sclerotium, Atracylodis lanceae rhizoma, and Atractylodes lancea rhizome (Table 2). Processed aconite root is the most important ingredient in shinbuto. Together with ginger, it warms the body and increases metabolism. Poria sclerotium and Atracylodis lanceae rhizoma work together to fix the body fluid imbalance. Paeoniae radix relaxes the strain of the smooth muscle of the gastrointestinal tract.– Together, these components ameliorate hie and suitai.
Table 2

Ingredients of Shinbuto

Poria sclerotium4.0 g
Atracylodis lanceae rhizoma3.0 g
Paeoniae radix3.0 g
Zingiberis rhizoma1.5 g
Aconiti tuber0.5 g
Ingredients of Shinbuto Kampo medicines other than shinbuto—eg, goreisan, hachimijiogan, and keishikashakuyakuto—could have been considered as well. Goreisan improves suitai and has been shown to be widely effective for dizziness in patients with edema, thirst, decreased urine output, and diarrhea. However, goreisan is not effective at warming the body. Hachimijiogan improves age-induced hie. Indeed, it is frequently used in elderly patients for jitsusho. Keishikashakuyakuto ameliorates abdominal distension (fukuman) caused by retention of stool and gas in the digestive tract of patients with hie. Our patient, however, did not have fukuman.

CONCLUSIONS

Shinbuto, a traditional Japanese herbal product, improved refractory diarrhea and abdominal pain in a patient with congenital leg lymphedema. The mechanism of action of shinbuto can be explained by rewarming and fixing body fluid imbalance.
  17 in total

1.  [The effects of kampo-formulation and the constituting crude drugs, prescribed for the treatment of peptic ulcer on H,K-ATPase activity].

Authors:  K Satoh; F Nagai; T Seto; H Yamauchi
Journal:  Yakugaku Zasshi       Date:  2001-02       Impact factor: 0.302

2.  Value of isotope lymphography in the diagnosis of lymphoedema of the leg.

Authors:  K G Burnand; C L McGuinness; N R F Lagattolla; N L Browse; A El-Aradi; T Nunan
Journal:  Br J Surg       Date:  2002-01       Impact factor: 6.939

3.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Authors:  M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

4.  Lymphoscintigraphy and colour Doppler sonography in the assessment of leg oedema of unknown cause.

Authors:  D C Wheatley; M L Wastie; S C Whitaker; A C Perkins; B R Hopkinson
Journal:  Br J Radiol       Date:  1996-12       Impact factor: 3.039

Review 5.  The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2003-06       Impact factor: 1.286

6.  Three children with Milroy disease and de novo mutations in VEGFR3.

Authors:  C Carver; G Brice; S Mansour; P Ostergaard; P Mortimer; S Jeffery
Journal:  Clin Genet       Date:  2007-02       Impact factor: 4.438

7.  Studies on the origin, processing and quality of crude drugs. II. Pharmacological evaluation of the Chinese crude drug "zhu" in experimental stomach ulcer. (2). Inhibitory effect of extract of Atractylodes lancea on gastric secretion.

Authors:  M Nogami; T Moriura; M Kubo; T Tani
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-09       Impact factor: 1.645

8.  Dual-frequency ultrasound examination of skin and subcutis thickness in breast cancer-related lymphedema.

Authors:  Russell H Mellor; Nigel L Bush; Anthony W B Stanton; Jeff C Bamber; J Rodney Levick; Peter S Mortimer
Journal:  Breast J       Date:  2004 Nov-Dec       Impact factor: 2.431

9.  The inheritance of primary lymphoedema.

Authors:  R F Dale
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

10.  Fluorescence microlymphography.

Authors:  A Bollinger; K Jäger; F Sgier; J Seglias
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.